Quadrant Capital Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,000
| Closed | -$536K | – | 2782 |
|
|
2023
Q4 | $536K | Buy |
+6,000
| New | +$536K | 0.05% | 287 |
|
|
2023
Q2 | – | Sell |
-261
| Closed | -$19.9K | – | 2780 |
|
|
2023
Q1 | $19.9K | Sell |
261
-825
| -76% | -$62.9K | ﹤0.01% | 1704 |
|
|
2022
Q4 | $90.1K | Buy |
1,086
+760
| +233% | +$63.1K | 0.01% | 841 |
|
|
2022
Q3 | $26K | Hold |
326
| – | – | ﹤0.01% | 1418 |
|
|
2022
Q2 | $24K | Buy |
326
+152
| +87% | +$11.2K | ﹤0.01% | 1221 |
|
|
2022
Q1 | $16K | Buy |
+174
| New | +$16K | ﹤0.01% | 1451 |
|